| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

Terrosa® osteoporosis biosimilar treatment launched in Europe

Increase font size  Decrease font size Date:2019-08-26   Views:56

The biosimilar teriparatide, Terrosa®, has been launched in Europe. The drug is approved in adults for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture as well as for osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028